News | Radiation Dose Management | November 18, 2016

Philips Introduces DoseWise Portal 2.2 at RSNA 2016

New connectivity capabilities and enhanced customization features further integrate radiology data to mitigate radiation risk for patients and staff

Philips, DoseWise Portal 2.2, RSNA 2016, radiation dose management

November 18, 2016 — Philips introduced DoseWise Portal 2.2, a next-generation radiation dose management software platform for healthcare providers to record, track and analyze radiation exposure to patients and clinicians. The latest version of DoseWise Portal includes enhanced connectivity and informatics capabilities to address key challenges faced by radiology departments, such as managing dose exposure to ensure patient and staff wellbeing, and improving integrated access to patient information to deliver data-driven decision support.

Radiation dose management and safety are growing concerns as clinicians and health systems comply with new Joint Commission standards related to computed tomography (CT) imaging protocols and dose optimization. Additionally, the new Centers for Medicare & Medicaid Services (CMS) payment program, MACRA, includes dose management-related requirements clinicians must follow for more accurate and complete reimbursement.

Philips will demonstrate DoseWise Portal 2.2 (still in the research phase of development) at this year's Radiological Society of North America (RSNA) annual meeting, Nov. 27-Dec. 1 in Chicago. Demonstrations will highlight the platform’s new capabilities, including integration with Philips IntelliBridge Enterprise for HL7 functionality and IntelliSpace PACS (picture archiving and communication system). Collectively, these new features enable clinicians to access more patient information, helping them to more easily interpret patient radiation dose per exam across modalities and analyze overall cumulative exposure.

Philips DoseWise Portal 2.2 integrates with key Philips health IT systems as well as third-party radiology dictation software to provide radiologists with greater patient information access and data capture for more informed decision support about dose management. DoseWise Portal 2.2 is now integrated with:

  • IntelliSpace PACS – Users may view the patient's exam radiation exposure directly from the PACS image, or by retrieving the patient's total radiation exposure exam history from the modality worklist;
  • IntelliBridge Enterprise – Allows users to query/retrieve crucial updated patient demographics from the hospital's electronic medical record (EMR), such as body mass index (BMI) weight and age, for use with the DoseWise Portal; and
  • Radiology dictation software – Enables patient radiation exposure to be populated into dictation reports, saving time and helping to reduce transcription errors.

DoseWise 2.2 is a multi-vendor and multi-modality solution that collects patient radiation dose data from X-ray modalities and allows for enhanced customer data analysis. In addition to the expanded integrations, the platform also includes:

  • Expanded connectivity to Philips DoseAware products – Compatibility with DoseAware and DoseAware Xtend combines patient and staff dose information into a single display for deep analytics of radiation exposure. The entire family of DoseAware products are now compatible with DoseWise Portal; and
  • Customized user-friendly Analytics Package – Intuitive user interface and enhanced "Chart Builder" charting and graphing functionality simplifies reporting needs and includes a customizable dashboard and popular reporting formats.

For more information: www.usa.philips.com/healthcare

Related Content

icobrain cva allows the quantitative assessment of tissue perfusion by reporting the volume of core and perfusion lesion by quantifying Tmax abnormality and CBF abnormality together with the mismatch volume and ratio
News | Artificial Intelligence | February 23, 2021
February 23, 2021 — icometrix, world leader in imaging...
Dr Sahar Saleem placing the mummy in the CT scanner

Dr. Sahar Saleem placing the mummy in the CT scanner. Image courtesy of Sahar Saleem

News | Computed Tomography (CT) | February 22, 2021
February 22, 2021 — Modern medical technology is helping scholars tell a more nuanced story about the fate of an anci
Examples of the imaging performance of XPCI-CT (b,e) compared to conventional specimen radiography (a,d) and benchmarked against histopathology (c,f). he top row focuses on the similarity between the XPCI-CT slice in (b) and the histological slice in (c). Arrow 1 indicates margin involvement, arrow 2 a variation in density in the internal structure of the tumour mass, arrow 3 tumour-induced inflammation. All this is confirmed by the histological slice in (c), and hardly visible in the conventional image in

Examples of the imaging performance of XPCI-CT (b,e) compared to conventional specimen radiography (a,d) and benchmarked against histopathology (c,f). he top row focuses on the similarity between the XPCI-CT slice in (b) and the histological slice in (c). Arrow 1 indicates margin involvement, arrow 2 a variation in density in the internal structure of the tumour mass, arrow 3 tumour-induced inflammation. All this is confirmed by the histological slice in (c), and hardly visible in the conventional image in (a). The bottom row focuses on the detection of small calcifications, a key feature in DCIS. These are undetectable in (d), detected in (e), enhanced in the maximum intensity projection (MIP) image at the bottom of (f), and confirmed by histopathology in the top part of (f). The scale bar [shown in (b) and (e)] is the same for all images apart from (f), which has its own scale. Red arrows in (e) and (f) indicate the microcalcifications. Image courtesy of Professor Alessandro Olivo

News | Breast Imaging | February 22, 2021
February 22, 2021 — A new X-ray imaging scanne
Unhealthy lifestyles, various diseases, stress, and aging can all contribute to an imbalance between the production of ROS and the body's ability to reduce and eliminate them. The resulting excessive levels of ROS cause "oxidative stress".

Unhealthy lifestyles, various diseases, stress, and aging can all contribute to an imbalance between the production of ROS and the body's ability to reduce and eliminate them. The resulting excessive levels of ROS cause "oxidative stress". Graphic courtesy of National Institutes for Quantum and Radiological Science and Technology

News | Magnetic Resonance Imaging (MRI) | February 10, 2021
February 10, 2021 — Oxygen is essential for human life, but within the body, certain biological environmental conditi
Real Time Imaging Technologies LLC iannounced that it has received U.S. Patent No. 10,898,070 IMAGING APPARATUS AND METHODS which covers the company’s methods for incorporating microlens into X-ray imaging detectors that enables significantly lower radiation dose without compromising image resolution.

Getty Images

News | Radiation Dose Management | February 05, 2021
February 5, 2021 — 
Materialise engineers coordinated the development of a surgical plan and created an on-screen 3D model based on CT-scans.

Materialise engineers coordinated the development of a surgical plan and created an on-screen 3D model based on CT-scans.

Feature | Medical 3-D Printing | February 03, 2021
Three-dimensional technologies, developed by Materialise
Kaplan–Meier curves for the high-risk individuals and the ones with low or medium risk according to AI-severity. The threshold to assign individuals into a high-risk group was the 2/3 quantile of the AI-severity score computed for patients of the KB development cohort. a Kaplan–Meier curves were obtained for the 150 leftover KB patients from the development cohort. b Kaplan–Meier curves were obtained for the 135 patients of the IGR validation cohort. p-values for the log-rank test were equal to 4.77e–07 (KB

Kaplan–Meier curves for the high-risk individuals and the ones with low or medium risk according to AI-severity. The threshold to assign individuals into a high-risk group was the 2/3 quantile of the AI-severity score computed for patients of the KB development cohort. a Kaplan–Meier curves were obtained for the 150 leftover KB patients from the development cohort. b Kaplan–Meier curves were obtained for the 135 patients of the IGR validation cohort. p-values for the log-rank test were equal to 4.77e–07 (KB) and 4.00e–12 (IGR). The two terciles used to determine threshold values for low-, medium-, and high-risk groups were equal to 0.187 and 0.375. Diamonds correspond to censoring of patients who were still hospitalized at the time when data ceased to be updated. The bands correspond to the sequence of the 95% confidence intervals of the survival probabilities for each day. KB Kremlin-Bicêtre hospital, IGR Institut Gustave Roussy hospital. Courtesy of Nature Communications.

News | Coronavirus (COVID-19) | February 01, 2021
February 1, 2021 — COVID-19...